Lawrence N. Kwong, Ph.D.
Affiliations: | 2006 | University of Wisconsin, Madison, Madison, WI |
Area:
Genetics, Cell Biology, Molecular Biology, OncologyGoogle:
"Lawrence Kwong"Parents
Sign in to add mentor| William F. Dove | grad student | 2006 | UW Madison | |
| (Mechanisms of loss of heterozygosity at Apc in mouse and rat knockout models of colon cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chagani S, De Macedo MP, Carapeto F, et al. (2023) MULTIPLATFORM ANALYSIS OF INTRATUMORAL PTEN HETEROGENEITY IN MELANOMA. The Journal of Investigative Dermatology |
| Romano G, Paradiso F, Li P, et al. (2023) Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma. Cancer Immunology Research |
| Koleilat MK, Kwong LN. (2020) Same Name, Different Game: EGFR Drives Intrinsic KRAS Inhibitor Resistance in Colorectal Cancer. Cancer Discovery. 10: 1094-1096 |
| Lapin M, Huang HJ, Javle M, et al. (2020) Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors Clinical Trials |
| Carapeto FCL, Soto LMS, Foo WC, et al. (2020) Abstract 2658: Immunological and mutational landscape of gallbladder adenocarcinoma Cancer Research. 80: 2658-2658 |
| Aloia A, Müllhaupt D, Chabbert CD, et al. (2019) A fatty acid oxidation-dependent metabolic shift regulates the adaptation of -mutated melanoma to MAPK inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Moss TJ, Rodon Ahnert J, Oakley HD, et al. (2019) Baseline cfDNA characteristics and evolution of cfDNA profile during treatment with selective FGFR inhibitor TAS-120. Journal of Clinical Oncology. 37: 3056-3056 |
| Korkut A, Zaidi S, Kanchi RS, et al. (2018) A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Systems |
| Romano G, Kwong LN. (2018) BRAF Dimerization: An Underlying Resistance Mechanism in Low-Grade Pediatric Gliomas. Cancer Discovery. 8: 1064-1065 |
| Sanchez-Vega F, Mina M, Armenia J, et al. (2018) Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 173: 321-337.e10 |